1. Drug prescription in Italy

   • M. Maggini
   • R. Raschetti
   • G. Traversa

   Pharmacoepidemiology And Prescription Pages: 429 - 430

2. ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in Prescription-Event Monitoring

   • K. Kubota
   • N. Kubota
   • W. H. W. Inman

   Pharmacoepidemiology And Prescription Pages: 431 - 437

3. Cough due to ace inhibitors: a case-control study using automated general practice data

   • L. E. Visser
   • B. H. Ch. Stricker
   • J. van der Lei

   Pharmacoepidemiology And Prescription Pages: 439 - 444

4. How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries

   • F. Avanzini
   • G. Tognoni
   • A. Herxheimer

   Pharmacoepidemiology And Prescription Pages: 445 - 450

5. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril

   • S. Antila
   • L. Lehtonen
   • U. Planken

   Pharmacodynamics Pages: 451 - 458

6. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers

   • A. Lönnebo
   • A. Grahnén
   • S.-Å. Eckernäs

   Pharmacodynamics Pages: 459 - 463

7. Improved pharmacodynamics of l-asparaginase-loaded in human red blood cells

   • R. Kravtzoff
   • C. Ropars
   • Ch. Valat

   Pharmacodynamics Pages: 465 - 470

8. A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure

   • J. C. McElnay
   • T. A. Al-Furaih
   • D. P. Nicholls

   Pharmacokinetics And Disposition Pages: 471 - 476

9. Pharmacokinetics of dexamethasone in premature neonates

   • R. A. Lugo
   • M. C. Nahata
   • E. McClead

   Pharmacokinetics And Disposition Pages: 477 - 483

10. Therapeutic monitoring of nalbuphine: transplacental transfer and estimated pharmacokinetics in the neonate

    • E. Nicolle
    • P. Devillier
    • C. Durand

    Pharmacokinetics And Disposition Pages: 485 - 489

11. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions

    • N. Rizzo
    • J. -M. Scherrmann
    • C. Girre

    Pharmacokinetics And Disposition Pages: 491 - 495

12. Pharmacokinetics of quinine in patients with chronic renal failure

    • P. Rimchala
    • J. Karbwang
    • K. Na-Bangchang

    Pharmacokinetics And Disposition Pages: 497 - 501

13. Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake

    • S. H. Sindrup
    • K. Brøsen
    • C. Broen Christensen

    Pharmacokinetics And Disposition Pages: 503 - 509

14. The anti-ulcer drug sucralfate does not affect gastric nicotine levels

    • G. Lindell
    • H. Graffner

    Pharmacokinetics And Disposition Pages: 511 - 513

15. Prostaglandin E₁ increases binding of ¹²³I-low-density lipoprotein to the human liver in vivo

    • H. Sinzinger
    • I. Virgolini
    • W. Rogatti

    Pharmacokinetics And Disposition Pages: 515 - 520

16. Acute tubular necrosis following high-dose cyclosporine A therapy

    • P. Shechter

    Case Report Pages: 521 - 523

17. Announcements

    Announcement Pages: 524 - 524

18. Prostaglandin E1 increases binding of 123I-low-density lipoprotein to the human liver in vivo

    • H. Sinzinger
    • H. Kritz
    • W. Rogatti

    PHARMACOKINETICS AND DISPOSITION Pages: 515 - 520